β-blockers: New standard therapy for heart failure

Mayo Clinic Proceedings

Volumn 77, Issue 8, 2002, Pages 839-846

  Pritchett, Allison M ^a   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; METOPROLOL; PLACEBO;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HUMAN; LETHALITY; MEDICAL SOCIETY; META ANALYSIS; MORBIDITY; PRACTICE GUIDELINE; PREVALENCE; SYSTOLIC BLOOD PRESSURE;

EID: 0036323821     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.8.839     Document Type: Conference Paper

References (37)

1. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
2. Diastolic heart failure in the community
3. Congestive heart failure: Fifty years of progress
4. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
5. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade
6. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
7. Basic mechanisms of disease progression in the failing heart: The role of excessive adrenergic drive
8. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
9. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
10. Effect of carvedilol on survival in severe chronic heart failure
11. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
12. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
13. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
14. A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
15. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
16. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
17. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
18. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995
19. Effects of bucindolol on neurohormonal activation in congestive heart failure
20. Beta-blocking agents in heart failure: Should they be used and how?
21. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE Trial
22. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
23. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
24. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
25. Usefulness of bucindolol in congestive heart failure
26. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy
27. Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents
28. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the Studies of Left Ventricular Dysfunction
29. Major β blocker mortality trials in chronic heart failure: A critical review
30. Sex differences in the prognosis of congestive heart failure: Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II)
31. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
32. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure
33. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma
34. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
35. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
36. Acute hemodynamic and neurohumoral effects of pindolol: A beta-adrenoceptor antagonist with high intrinsic sympathomimetic activity in patients with dilated cardiomyopathy
37. Bisoprolol dose-response in the Cardiac Insufficiency Bisoprolol Study (CIBIS II)